Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Journal of Gastroenterology|May 29, 2007
Association of tannase-producing Staphylococcus lugdunensis with colon cancer and characterization of a novel tannase geneNorihisa Noguchi, Takashi Ohashi, Taisei Shiratori, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 3, 2020
A risk as an infection route: Nasal colonization of methicillin-resistant Staphylococcus aureus USA300 clone among contact sport athletes in JapanMariko Moriya, Junya Tsurukiri, Hidemasa Nakaminami, et al.
Journal of Gastroenterology and Hepatology|November 22, 2011
Effect of pretreatment with Lactobacillus gasseri OLL2716 on first-line Helicobacter pylori eradication therapyRyuzo Deguchi, Hidemasa Nakaminami, Emiko Rimbara, et al.
Hepato-Gastroenterology|July 11, 2008
A study of the relationship between Helicobacter pylori microbial susceptibility, 13C-urea breath test valuesTakashi Kawai, Kohei Kawakami, Mikinori Kataoka, et al.
Clinical Nephrology|September 10, 2019
Glyceraldehyde-3-phosphate dehydrogenase of Mycoplasma pneumoniae induces infection-related glomerulonephritisDaishi Hirano, Takashi Oda, Akira Ito, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 4, 2018
Comparative analysis of methicillin-resistant Staphylococcus aureus isolated from outpatients of dermatology unit in hospitals and clinicsHidemasa Nakaminami, Taku Sugiyama, Yuu Okamura, et al.
The Journal of Dermatology|February 26, 2019
Clonal change of methicillin-resistant Staphylococcus aureus isolated from patients with impetigo in Kagawa, JapanNao Sasai, Hidemasa Nakaminami, Manami Iwasaki, et al.
Hepato-Gastroenterology|May 26, 2007
Efficacy of low-dose proton pump inhibitor (PPI) in the eradication of Helicobacter pylori following combination PPI/AC therapy in JapanTakashi Kawai, Kohei Kawakami, Kataoka Mikinori, et al.
Journal of Gastroenterology and Hepatology|January 6, 2009
Tailored eradication therapy based on fecal Helicobacter pylori clarithromycin sensitivitiesTakashi Kawai, Tetsuya Yamagishi, Kenji Yagi, et al.
Pageof 12